18 research outputs found
The urgent need for integrated science to fight COVID-19 pandemic and beyond
The COVID-19 pandemic has become the leading societal concern. The pandemic has shown that the public health
concern is not only a medical problem, but also afects society as a whole; so, it has also become the leading scientifc
concern. We discuss in this treatise the importance of bringing the world’s scientists together to fnd efective solu‑
tions for controlling the pandemic. By applying novel research frameworks, interdisciplinary collaboration promises to
manage the pandemic’s consequences and prevent recurrences of similar pandemics
Manufacture Techniques of Chitosan-Based Microcapsules to Enhance Functional Properties of Textiles
In recent years, the textile industry has been moving to novel concepts of products, which could deliver to the user, improved performances. Such smart textiles have been proven to have the potential to integrate within a commodity garment advanced feature and functional properties of different kinds. Among those functionalities, considerable interest has been played in functionalizing commodity garments in order to make them positively interact with the human body and therefore being beneficial to the user health. This kind of functionalization generally exploits biopolymers, a class of materials that possess peculiar properties such as biocompatibility and biodegradability that make them suitable for bio-functional textile production. In the context of biopolymer chitosan has been proved to be an excellent potential candidate for this kind of application given its abundant availability and its chemical properties that it positively interacts with biological tissue. Notwithstanding the high potential of chitosan-based technologies in the textile sectors, several issues limit the large-scale production of such innovative garments. In facts the morphologies of chitosan structures should be optimized in order to make them better exploit the biological activity; moreover a suitable process for the application of chitosan structures to the textile must be designed. The application process should indeed not only allow an effective and durable fixation of chitosan to textile but also comply with environmental rules concerning pollution emission and utilization of harmful substances. This chapter reviews the use of microencapsulation technique as an approach to effectively apply chitosan to the textile material while overcoming the significant limitations of finishing processes. The assembly of chitosan macromolecules into microcapsules was proved to boost the biological properties of the polymer thanks to a considerable increase in the surface area available for interactions with the living tissues. Moreover, the incorporation of different active substances into chitosan shells allows the design of multifunctional materials that effectively combine core and shell properties. Based on the kind of substances to be incorporated, several encapsulation processes have been developed. The literature evidences how the proper choices concerning encapsulation technology, chemical formulations, and process parameter allow tuning the properties and the performances of the obtained microcapsules. Furthermore, the microcapsules based finishing process have been reviewed evidencing how the microcapsules morphology can positively interact with textile substrate allowing an improvement in the durability of the treatment. The application of the chitosan shelled microcapsules was proved to be capable of imparting different functionalities to textile substrates opening possibilities for a new generation of garments with improved performances and with the potential of protecting the user from multiple harms. Lastly, a continuous interest was observed in improving the process and formulation design in order to avoid the usage of toxic substances, therefore, complying with an environmentally friendly approach
Wettability Control on ZnO Nanowires Driven by Seed Layer Properties
This study proposes a way to control the wettability of zinc oxide nanowires (NWs) by properly selecting the kind of seed layer used to promote the growth of the wires. ZnO seed layers were synthesized on silicon and conductive substrates by a physical vapor deposition approach and a wet-chemical route, namely, the radio frequency magnetron sputtering and the spin-coating techniques, respectively. ZnO NWs were grown by a hydrothermal method on each kind of seed layer and the results were compared. The morphologies and crystallographic orientations of the seed layers and the resulting NWs were investigated with the aim of correlating the characteristics of the underlying seed layer to those of the resulting NWs. Additional insights were obtained by performing optical contact angle (OCA) measurements on ZnO seed layers to study their wettability behavior immediately after the synthesis processes and two weeks later. Hydrophilic behavior was observed in both sputtered and spin-coated fresh seed layers. After two weeks of aging, a change in the wettability and a net transition from hydrophilic to hydrophobic behavior was observed in sputtered seed layers, whereas in the spin-coated films this transition was not so pronounced and was found to be dependent on the precursor concentration. OCA measurements carried out on ZnO NWs showed that the wettability of the NWs is strictly related to the nature of the underlying seed layers and does not depend on the aging time, in contrast to the behavior of the seed layers. Depending on the deposition method, we therefore obtained either highly hydrophilic or superhydrophobic nanowires, which demonstrates the possibility to strongly control the final wetting behavior of these nanostructures for the desired application, such as self-cleaning surfaces, antireflection coatings, or substrates to anchor biofunctional agent
Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization
Confinement in Oriented Mesopores Induces Piezoelectric Behavior of Polymeric Nanowires
We report on the preparation and the piezoelectric properties of ultrathin polymeric nanowires in the oriented pores of mesoporous silica, which are embedded in the channels of a supporting anodic alumina membrane. Poly(vinylidene difluoride) [PVDF] and its copolymer; poly(vinylidene difluoride trifluoroethylene) [PVTF], were both confined to two types of columnar silica mesopores of similar to 5 and 10 nm in diameter. The extreme spatial confinement induces a preferential orientation of the crystalline domains of the polymer into a ferroelectric phase, leading to ultrahigh-aspect-ratio nanowires distributed throughout the templating host, and having up to 60 mu m in length, comparable to the thickness of the hosting alumina. The resulting distributed array of piezoelectric nanowires are isolated from each other by a dielectric matrix, facilitating the handling and electrical contacting. We show, for the first time, that a remarkable piezo-response, in the absence of any poling or stretching, is obtained upon nanoconfinement on the PVDF polymer, which, in contrast, does not show any polarization when in bulk or film form without poling. The piezoelectric behavior was assessed by a piezo evaluation system (PES) and we visualized polar nanowire bundles via piezoresponse force microscopy (PFM). This "nano-structuration" represents a powerful approach, holding promise for applications for nanoactuators or bioinspired ciliated sensors with high sensitivity and resolution
Functionalized ZnO nanowires for microcantilever biosensors with enhanced binding capability
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
The high potency and tolerability of the currently available antiretroviral drugs has modified HIV-1 infection from a life-threatening disease to a chronic illness. Nevertheless, some issues still remain open to optimize the management of HIV-1 infected patients in term of maintenance of virological suppression over time, identifying patients that could benefit from simplification therapy, and reducing co-mordibities driven by chronic inflammation. The availability of robust and affordable virological and immunological markers can help in solving these issues by providing information on the burden of HIV-1 reservoir in all the anatomical compartments in which the virus replicates as well as on persistent inflammation, immune activation and senescence despite successful virological suppression. In this light, this review is aimed at providing new insights (arising from a two-day Italian expert meeting hold in Rome in March 2016) in evaluation and monitoring of HIV-1 infection from a virological, immunological and clinical perspective. Particular attention has been focused on role of novel parameters (such as total HIV-1 DNA, residual viremia, and immunological markers) in optimizing treatment strategies, enhancing medical adherence, and individualizing monitoring
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
The high potency and tolerability of the currently available antiretroviral drugs has modified HIV-1 infection from a life-threatening disease to a chronic illness. Nevertheless, some issues still remain open to optimize the management of HIV-1 infected patients in term of maintenance of virological suppression over time, identifying patients that could benefit from simplification therapy, and reducing co-mordibities driven by chronic inflammation. The availability of robust and affordable virological and immunological markers can help in solving these issues by providing information on the burden of HIV-1 reservoir in all the anatomical compartments in which the virus replicates as well as on persistent inflammation, immune activation and senescence despite successful virological suppression. In this light, this review is aimed at providing new insights (arising from a two-day Italian expert meeting hold in Rome in March 2016) in evaluation and monitoring of HIV-1 infection from a virological, immunological and clinical perspective. Particular attention has been focused on role of novel parameters (such as total HIV-1 DNA, residual viremia, and immunological markers) in optimizing treatment strategies, enhancing medical adherence, and individualizing monitoring
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
The high potency and tolerability of the currently available antiretroviral drugs has modified HIV-1 infection from a life-threatening disease to a chronic illness. Nevertheless, some issues still remain open to optimize the management of HIV-1 infected patients in term of maintenance of virological suppression over time, identifying patients that could benefit from simplification therapy, and reducing co-mordibities driven by chronic inflammation. The availability of robust and affordable virological and immunological markers can help in solving these issues by providing information on the burden of HIV-1 reservoir in all the anatomical compartments in which the virus replicates as well as on persistent inflammation, immune activation and senescence despite successful virological suppression. In this light, this review is aimed at providing new insights (arising from a two-day Italian expert meeting hold in Rome in March 2016) in evaluation and monitoring of HIV-1 infection from a virological, immunological and clinical perspective. Particular attention has been focused on role of novel parameters (such as total HIV-1 DNA, residual viremia, and immunological markers) in optimizing treatment strategies, enhancing medical adherence, and individualizing monitoring
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
The high potency and tolerability of the currently available antiretroviral drugs has modified HIV-1 infection from a life-threatening disease to a chronic illness. Nevertheless, some issues still remain open to optimize the management of HIV-1 infected patients in term of maintenance of virological suppression over time, identifying patients that could benefit from simplification therapy, and reducing co-mordibities driven by chronic inflammation. The availability of robust and affordable virological and immunological markers can help in solving these issues by providing information on the burden of HIV-1 reservoir in all the anatomical compartments in which the virus replicates as well as on persistent inflammation, immune activation and senescence despite successful virological suppression. In this light, this review is aimed at providing new insights (arising from a two-day Italian expert meeting hold in Rome in March 2016) in evaluation and monitoring of HIV-1 infection from a virological, immunological and clinical perspective. Particular attention has been focused on role of novel parameters (such as total HIV-1 DNA, residual viremia, and immunological markers) in optimizing treatment strategies, enhancing medical adherence, and individualizing monitoring